EMERALD ADVISERS, LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 125 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$45,000
-30.8%
21,9500.0%0.00%
-33.3%
Q2 2019$65,000
-67.5%
21,950
-59.0%
0.00%
-62.5%
Q1 2019$200,000
-6.5%
53,5200.0%0.01%
-27.3%
Q4 2018$214,000
-46.6%
53,520
-25.8%
0.01%
-26.7%
Q3 2018$401,000
+75.9%
72,125
+24.3%
0.02%
+66.7%
Q2 2018$228,000
+76.7%
58,045
+185.6%
0.01%
+80.0%
Q3 2017$129,000
+48.3%
20,323
+84.0%
0.01%
+25.0%
Q2 2017$87,000
+19.2%
11,0430.0%0.00%
+33.3%
Q1 2017$73,000
-5.2%
11,043
-0.8%
0.00%0.0%
Q4 2016$77,000
-95.9%
11,132
-94.5%
0.00%
-96.5%
Q3 2016$1,899,000
+32.6%
203,737
+31.5%
0.08%
+23.2%
Q2 2016$1,432,000
+1.8%
154,986
-4.1%
0.07%0.0%
Q1 2016$1,407,000
-50.0%
161,539
-61.4%
0.07%
-48.1%
Q4 2015$2,813,000
+16.2%
418,6460.0%0.13%
+5.6%
Q3 2015$2,420,000
+2.8%
418,646
+45.1%
0.13%
+12.5%
Q2 2015$2,354,000
+169.3%
288,486
+220.5%
0.11%
+154.5%
Q1 2015$874,000
+9.7%
89,999
+3.6%
0.04%
+4.8%
Q4 2014$797,000
-12.4%
86,859
-5.9%
0.04%
-22.2%
Q3 2014$910,000
-8.6%
92,350
+0.3%
0.05%
-3.6%
Q2 2014$996,00092,1150.06%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Sante Capital Fund, LP 115,637$1,072,0000.44%
Defender Capital, LLC. 135,466$1,255,0000.42%
Green Alpha Advisors, LLC 62,566$580,0000.40%
Harvest Investment Services, LLC 51,239$474,0000.20%
SEVEN EIGHT CAPITAL, LP 118,270$1,096,0000.15%
Cedar Brook Financial Partners, LLC 54,500$505,0000.15%
WASATCH ADVISORS LP 3,576,706$33,156,0000.14%
Banco BTG Pactual S.A. 20,000$185,0000.12%
Keystone Financial Group 60,712$563,0000.10%
Virtus ETF Advisers LLC 25,105$233,0000.10%
View complete list of INOVIO PHARMACEUTICALS INC shareholders